To confirm that the observed growth inhibition of hypoxic tumors stems from lower available glucose rather than lower insulin [51, 52] or a modulation of the immune response mediated by the glucose consumption-dependent N-glycosylation [53], we replicated the oxygen-starved tumor microenvironment in vitro. The gene discussed is INS; the disease is neoplasm.